Suplementação oral de nitrato de sódio restaura a regulação do fluxo sanguíneo na distrofia muscular de Becker

6 de abril de 2014 by Izabel Gavinho

USA – o nitrato de sódio é uma droga doadora de óxido nítrico, um potente vasodiltador. A droga foi usada em 6 homens com distrofia muscular de Becker. Submetidos a atividade física o tratamento impediu a redução do fluxo sanguíneo, importante para a função muscular, de todas as formas de distrofia muscular.

O resumo em inglês pode ser lido abaixo:

(Experimental Biology, 2014) Dietary sodium nitrate supplementation restores blood flow regulation in Becker muscular

Michael Nelson, Florian Rader, Xiu Tang, Thomas Stabler, Jason Allen, and Ronald Victor – USA

Chronic administration of a nitric oxide-donating drug fully corrects abnormal blood flow regulation in the mdx mouse model of dystrophinopathy. As a first step to clinical translation, we treated 6 men with Becker muscular dystrophy with a single oral dose of sodium nitrate- a simple, exogenous inorganic nitric oxide donor. We measured reflex vasoconstriction (ΔHb02, near infrared spectroscopy; evoked by lower body negative pressure) at rest and during rhythmic handgrip exercise, before and 3 hours after ~8.4 mmol of oral sodium nitrate. Before treatment, blood flow regulation was impaired in BMD, because handgrip exercise caused no attenuation of reflex vasoconstriction (ΔHbO2:-17±2 vs. -16±2 %, rest vs. HG). Remarkably, sodium nitrate supplementation more than doubled plasma nitrate and nitrite levels, and restored exercise-induced attenuation of reflex vasoconstriction (ΔHbO2: -18±1 vs. -11±2; P <.001, rest vs. HG). Moreover, the exercise-induced increase in forearm muscle blood flow, as measured by Doppler ultrasound, nearly tripled after sodium nitrate supplementation (Δ from baseline: 102 + 19% before treatment compared to 271 + 39 % after treatment), despite having no effect on basal flow. Taken together, these data indicate that oral sodium nitrate can recapitulate the normal regulation of blood flow in exercising dystrophic skeletal muscle, which is normally achieved by sarcolemmal nNOS.

Fonte: http://distrofiamuscular.net/principal.htm

ACADIM. Todos os direitos reservados.